Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
3,093,398
-
Share change
-
+1,851,752
-
Total reported value
-
$5,909,239
-
Price per share
-
$1.91
-
Number of holders
-
20
-
Value change
-
+$3,413,791
-
Number of buys
-
7
-
Number of sells
-
8
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q4 2018
As of 31 Dec 2018,
Aptose Biosciences Inc. - Common Shares was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,093,398 shares.
The largest 10 holders included
DRW Securities, LLC, MORGAN STANLEY, Patriot Financial Group Insurance Agency, LLC, US BANCORP \DE\, Antipodean Advisors LLC, TWO SIGMA ADVISERS, LP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and ROYAL BANK OF CANADA.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.